Market Value2,826,432,000
Total Holdings83
File Date2021-05-17
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
INCY / Incyte Corporation
BMRN / BioMarin Pharmaceutical Inc.
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
NUAN / Nuance Communications Inc
BIIB / Biogen Inc.
COO / The Cooper Companies, Inc.
NVST / Envista Holdings Corporation
JNJ / Johnson & Johnson
IWM / iShares Trust - iShares Russell 2000 ETF Put
ANIK / Anika Therapeutics, Inc.
VEEV / Veeva Systems Inc.
CERN / Cerner Corp.
HZNP / Horizon Therapeutics Plc Call
ACAD / ACADIA Pharmaceuticals Inc.
LGV.U / Longview Acquisition Corp. II Units, each consisting of one share of Class A and one-fi
FNCH / Finch Therapeutics Group, Inc.
CMIIU / CM Life Sciences II Inc - Units (1 Ord Share Class A & 1/5 War)
RPRX / Royalty Pharma plc
HCA / HCA Healthcare, Inc.
MRVI / Maravai LifeSciences Holdings, Inc.
HAE / Haemonetics Corporation
CTLT / Catalent, Inc.
CLDX / Celldex Therapeutics, Inc. Call
SRSAU / Sarissa Capital Acquisition Corp - Units (1 Ord Share Class A & 1/3 War)
OHI / Omega Healthcare Investors, Inc.
HALO / Halozyme Therapeutics, Inc.
ELV / Elevance Health, Inc.
US0153511094 / Alexion Pharmaceuticals, Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
SHC / Sotera Health Company
ARYD / ARYA Sciences Acquisition Corp IV
CNTB / Connect Biopharma Holdings Limited - Depositary Receipt (Common Stock)
INNV / InnovAge Holding Corp.
CERT / Certara, Inc.
SYNH / Syneos Health Inc - Class A
FOLD / Amicus Therapeutics, Inc. Put
PRDS / Pardes Biosciences Inc
17K / Self Storage Group ASA
OHPA / Orion Acquisition Corp - Class A
HLXA / Helix Acquisition Corp - Class A
ALLO / Allogene Therapeutics, Inc.
TNGX / Tango Therapeutics, Inc.
KYG5960S1167 / Medicus Sciences Acquisition Corp. Unit
TVTX / Travere Therapeutics, Inc.
TIL / Instil Bio, Inc.
IQV / IQVIA Holdings Inc.
US33830X1046 / Five Prime Therapeutics Inc
ICUI / ICU Medical, Inc.
EHTH / eHealth, Inc.
QQQ / Invesco QQQ Trust, Series 1 Put
DHR / Danaher Corporation
ZTS / Zoetis Inc.
LIVN / LivaNova PLC
CRIS / Curis, Inc.
DCPH / Deciphera Pharmaceuticals, Inc.
WELL / Welltower Inc.
RARE / Ultragenyx Pharmaceutical Inc.
AUPH / Aurinia Pharmaceuticals Inc.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
NVRO / Nevro Corp.
GH / Guardant Health, Inc.
ALGN / Align Technology, Inc.
BIO / Bio-Rad Laboratories, Inc.
OMER / Omeros Corporation
RCUS / Arcus Biosciences, Inc.
VTR / Ventas, Inc.
AGIO / Agios Pharmaceuticals, Inc.
WOOF / Petco Health and Wellness Company, Inc.
MRUS / Merus N.V.
EW / Edwards Lifesciences Corporation
ABC / Amerisource Bergen Corp.
AFMD / Affimed N.V.
IKNA / Ikena Oncology, Inc.
BSX / Boston Scientific Corporation
IDXX / IDEXX Laboratories, Inc.
QGEN / Qiagen N.V.
OMEG / Omega Alpha SPAC - Class A
VRTX / Vertex Pharmaceuticals Incorporated
VRTX / Vertex Pharmaceuticals Incorporated Call
BMY / Bristol-Myers Squibb Company
MDT / Medtronic plc
EUCR / Eucrates Biomedical Acquisition Corp
TFX / Teleflex Incorporated
MDGL / Madrigal Pharmaceuticals, Inc.
CRL / Charles River Laboratories International, Inc.
EHC / Encompass Health Corporation
ABGI / ABG Acquisition Corp I - Class A
IRWD / Ironwood Pharmaceuticals, Inc.
ABBV / AbbVie Inc.
JNCE / Jounce Therapeutics Inc
JYAC / Jiya Acquisition Corp - Class A
ZBH / Zimmer Biomet Holdings, Inc.
ITCI / Intra-Cellular Therapies, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
MCK / McKesson Corporation
CYTK / Cytokinetics, Incorporated
RACB / Research Alliance Corp II - Class A
SNDX / Syndax Pharmaceuticals, Inc.
HOLX / Hologic, Inc.
CNMD / CONMED Corporation
UNH / UnitedHealth Group Incorporated
SPY / SPDR S&P 500 ETF Put
THC / Tenet Healthcare Corporation
DXCM / DexCom, Inc.
NBIX / Neurocrine Biosciences, Inc.
CI / The Cigna Group
HZNP / Horizon Therapeutics Plc
HUM / Humana Inc.